CN102993257A - New fulvestrant preparation method - Google Patents

New fulvestrant preparation method Download PDF

Info

Publication number
CN102993257A
CN102993257A CN 201110273964 CN201110273964A CN102993257A CN 102993257 A CN102993257 A CN 102993257A CN 201110273964 CN201110273964 CN 201110273964 CN 201110273964 A CN201110273964 A CN 201110273964A CN 102993257 A CN102993257 A CN 102993257A
Authority
CN
China
Prior art keywords
compound
formula
reaction
fulvestrant
environment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 201110273964
Other languages
Chinese (zh)
Inventor
陈玮琳
王腾
刘燕兵
廖贵林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUZHOU RONGDA MEDICINE CO Ltd
Original Assignee
HUZHOU RONGDA MEDICINE CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUZHOU RONGDA MEDICINE CO Ltd filed Critical HUZHOU RONGDA MEDICINE CO Ltd
Priority to CN 201110273964 priority Critical patent/CN102993257A/en
Publication of CN102993257A publication Critical patent/CN102993257A/en
Pending legal-status Critical Current

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

The present invention provides a new fulvestrant synthesis method. The technical scheme of the method comprises: adopting 6-ketoestradiol as a starting raw material, and adopting a six-step reaction to prepare fulvestrant, wherein reaction conditions are mild, the total yield is about 40%, product purity is high, all the raw materials are domestic chemical products, operation is convenient, cost is low, and the method is applicable for large-scale production.

Description

A kind of new preparation method of fulvestrant
Technical field
The present invention relates to a kind of estrogen receptor (ER) inhibitor-lower a kind of new preparation process of adjusting
Background technology
Fulvestrant (Fulvestrant), chemistry 7 α-[9-(4,4,5,5,5-, five fluorine amyl group sulfinyls) nonyl] by name-female-1,3,5 (10)-triolefins-3,17-isoallopregnane-3β, its structural formula is:
Fulvestrant is the anti-breast cancer new drug by the exploitation of Astrazeneca company.In 2002 in U.S.'s Initial Public Offering, and in 2004 by European Union's approval listing.Fulvestrant is the novel estrogen receptor blocker of a class, is used for the treatment of the postmenopausal women with advanced mammary cancer that the estrogen antagonist therapy for treating is invalid, estrogen receptor is positive.The listing of fulvestrant is to suffer from the postmenopausal women of mammary cancer to have brought new selection
US Patent No. 4659516 (EP0138504) discloses the synthetic method of a series of similar compounds of fulvestrant.This route obtains the finished product fulvestrant by the reaction of 10 steps from 6-dehydrogenation nandrolone acetic ester, reactions steps is very loaded down with trivial details, 7 α in the grignard reaction: 7 β=1.9: 1, and total molar yield is less than 10%.Its route is as follows:
The disclosed another kind of route of WO03031399 and WO02032922 also is from 6-dehydrogenation nandrolone acetic ester is raw material, used short synthetic route, but do not overcome the higher defective of impurity isomer 7 β content in the grignard reaction, its 7 α: 7 β=2.5: 1, and its intermediate does not all have the process of separation and purification, so the purifying of the finished product is very difficult.Its route is as follows:
Figure BSA00000574547300031
Figure BSA00000574547300041
US Patent No. 20060030552 and wo2006015081 then disclose the improvement route of upper 2 routes 7 α: the ratio of 7 β brings up to 7: 1-12: more than 1, but its step is longer, and have multistep to require column chromatography, be unfavorable for fairly large production, total recovery is not high.
Wo2009039700 discloses another synthesis mode, and the method makes fulvestrant through the reaction of 6 steps from estradiol is the beginning raw material, and multistep very low temperature (78 ℃) reaction and too much column chromatography are wherein arranged, and is not suitable for large-scale production.Its route is as follows:
Figure BSA00000574547300051
For these reasons, be necessary to develop a kind of simple effectively, cheaply, be suitable for the method for suitability for industrialized production fulvestrant.
Summary of the invention
In order to address the above problem, the invention provides a kind of preparation method of fulvestrant.
Preparation method of the present invention can represent with following reaction formula:
Figure BSA00000574547300061
Technical scheme of the present invention mainly may further comprise the steps:
(1) 6-ketoestradiol diacetate esters (Compound I I)
In a kind of aprotic polar solvent, such as amides, ketone, nitrile, methyl-sulphoxide, pyridine etc., preferred pyridine.Use a kind of esterification means commonly used protection hydroxyl, comprise acid anhydrides, acyl chlorides etc., first-selected aceticanhydride, aceticanhydride are suitably excessive, and temperature of reaction is at 0-100 ℃, preferred 25 ℃;
(2) 1-iodo-9-(4,4,5,5,5-, five fluorine, penta sulfenyl) nonane (compound IV) compound III is at methylene dichloride, in the inert solvents such as THF, use excessive acyl chlorides, such as methylsulfonyl chloride, Tosyl chloride etc., preferred active higher methylsulfonyl chloride and 9-(4,4,5,5,5-five fluorine penta sulfenyl)-and 1 nonyl alcohol is reacted into carboxylate, and temperature of reaction is at 0-40 ℃, preferred 25 ℃.Then in acetone with potassiumiodide generation substitution reaction, temperature of reaction is for refluxing, the reaction times is 12 hours, generates iodo compound IV
(3) 3,17 β-diacetate esters-7 α-[9-(4,4,5,5,5-, five fluorine, penta sulfenyl) nonyl]-female-1,3,5 (10)-triolefins-6-ketone
Compound I I and compound IV are at a kind of anhydrous non-protonic solvent, in ether, THF such as THF, use highly basic such as oxyhydroxide, potassium alcoholate, sodium alkoxide etc., preferred potassium tert.-butoxide, under lower temperature-78 ℃-0 ℃, alkylated reaction occurs, preferred-40 ℃ of temperature of reaction, reaction times 6-24 hour, preferred 12 hours.Product content is lower herein, needs to use column chromatography purification.The column chromatography eluent can be toluene, the sherwood oil mixed solution of ethyl acetate,
(4) 7 α-[9-(4,4,5,5,5-, five fluorine, penta sulfenyl) nonyl]-female-1,3,5 (10)-triolefins-3,17 β-diacetate esters
Compound V uses suitable reductive agent, and 6 carbonyl reductions are become methylene radical, such as Pd, and Pt, Ni sodium borohydride, the general reductive agent such as POTASSIUM BOROHYDRIDE, preferred palladium carbon.10% palladium carbon particularly preferably.Temperature of reaction 30-80 ℃, preferred 70 ℃, react and be normal pressure
(5) 7 α-[9-(4,4,5,5,5-, five fluorine, penta sulfenyl) nonyl]-female-1,3,5 (10)-triolefins-3,17-isoallopregnane-3β
Compound vi is hydrolyzed through highly basic, generates compound vi I, and wherein alkali is sodium hydroxide or potassium hydroxide
(6) fulvestrant
Compound vi I uses general gentle oxygenant, and sulphur is oxidized to sulfoxide, and wherein oxygenant is sodium periodate, metachloroperbenzoic acid, hydrogen peroxide etc., preferred sodium periodate.Obtain the crude product column chromatography and re-use the ethyl acetate crystallization, obtain high-purity fulvestrant after making with extra care
The technical program prepares fulvestrant take the 6-ketoestradiol as starting raw material by six-step process, and reaction conditions is gentle, and total recovery is about 40%, and product purity is high, and all raw materials are all the production domesticization chemical product, and are easy and simple to handle, and cost is low, is suitable for large-scale production.
Specific embodiments:
Embodiment 1
With 9g 9-(4,4,5,5,5. five fluorine, penta sulfenyl)-1 nonyl alcohol (0.028mol) is dissolved in the 100ml methylene dichloride, adds 4ml N, the N-diisopropylamine joins in the reaction flask, cool to 10 ℃, slowly drip the 2.3ml methylsulfonyl chloride, add, 25 ℃ were reacted 2 hours, add the water washing organic layer 3 times, anhydrous sodium sulfate drying, concentrating under reduced pressure is done.Add 150ml acetone, logical nitrogen protection adds the 6g potassiumiodide, and rapid stirring refluxed 12 hours, reacted complete, and the evaporated under reduced pressure dissolving adds 100ml water and 100ml toluene, and organic layer washes with water 2 times again.Be evaporated to driedly, get the 11g brown oil, column chromatography obtains the faint yellow oily thing of 9g, yield 75%.
Embodiment 2
Under the nitrogen protection, 15g estradiol-6-ketone (52mmol) is dissolved in the pyridine of 150ml drying, drips the 50ml aceticanhydride about 10 ℃, dropwise, 25 ℃ of reactions are spent the night, and TLC follows the tracks of, and raw material disappears, and is evaporated to dried.Obtain faint yellow oily thing 17.5g, yield 92%.
Embodiment 3
10g6-ketoestradiol diacetate esters (26.5mmol) is dissolved among the 30mlTHF, and 0 ℃ of THF solution that adds potassium tert.-butoxide adds, 0 ℃ of reaction 2 hours, cool to-40 ℃, slowly be added dropwise to 18g 1-iodo-9-(4,4,5,5,5-, five fluorine, penta sulfenyl) the 50mlTHF solution of nonane (70mmol) dropwises, slowly be warmed up to 0 ℃, insulation reaction is spent the night.React complete, add entry and ethyl acetate extraction, the organic layer anhydrous sodium sulfate drying is evaporated to driedly, obtains 15.5g, and use the ethyl acetate of 5%-20%: the sherwood oil column chromatography obtains weak yellow liquid to 10.8g, yield 59.2%.
Embodiment 4
With 3,17 β-diacetate esters-7 α-[9-(4,4; 5,5,5-, five fluorine, penta sulfenyl) nonyl]-female-1; 3,5 (10)-triolefins-6-ketone 11.8g (17.1mmol) are dissolved in the 150ml acetic acid; under the nitrogen protection; add 1g 10%Pd-C, be warmed up to 70 ℃, change nitrogen into hydrogen; insulation reaction 3 hours, TLC tracks to the raw material completely dissolve.Cooling is filtered, and filtrate adds 200ml ethyl acetate and 50ml water, separates organic layer, washing.Be concentrated into driedly, obtain oily matter 10.1g, yield 89%.
Embodiment 5
With reactant of upper step 7 α-[9-(4,4,5,5,5-, five fluorine, penta sulfenyl) nonyl]-female-1,3,5 (10)-triolefins-3,17 β-diacetate esters 10g (14.8mmol) is dissolved in the 100ml methyl alcohol, slowly adds the aqueous sodium hydroxide solution of 10g 50%.Room temperature reaction 5 hours, TLC follows the tracks of, and reacts complete, adds the 100ml ethyl acetate, tells the upper strata, water washing.Be concentrated into driedly, obtain the faint yellow oily thing of 7.9g, yield 91%.
Embodiment 6
18g is joined among 35ml methyl alcohol and the 100mlTHF, cool to 0 ℃, slowly drip 10% sodium periodate aqueous solution 150ml, add, 0 ℃ of insulation reaction 12 hours reacts complete, adds 150ml methylene dichloride and 50ml water, tell methylene dichloride, wash evaporated under reduced pressure 2 times.Add the oily matter that the 50ml acetic acid ethyl dissolution obtains, crystallization is 1 hour under 0 ℃ of stirring, filters the solid that obtains.After using the ethyl acetate decolorizing and refining behind the column chromatography, 30 ℃ of vacuum-dryings obtain the 12g white solid, yield 81%.

Claims (2)

1. a structural formula is suc as formula the compound of V:
Figure FSA00000574547200011
2. the preparation method of a fulvestrant is characterized in that, may further comprise the steps:
(1) Compound I and suitably excessive aceticanhydride, reaction generates compound II under 20-60 ℃ of environment, and wherein aceticanhydride also can be other protectiveness acid anhydrides;
(2) compound III in suitable solvent with methylsulfonyl chloride or Tosyl chloride etc. under 0-30 ℃ of environment, be reacted into carboxylate, be that suitable salt compounded of iodine replaces to generate compound IV
(3) substitution reaction under-78 ℃ to 0 ℃ environment, occurs and generates compound formula V in the non-proton organic solvents such as THF in formula II and formula IV
(4) compound V is through the reduction of 5%-10% palladium carbon, reacting generating compound formula VI, and wherein reductive agent also can be the reductive agent that other can reducing carbonyl, such as Pt-C, metallic reducing agent or the sodium borohydrides such as Ni, the general reductive agent such as POTASSIUM BOROHYDRIDE
(5) formula VI generates compound formula 7 through macromolecule alkali for hydrolysis, and wherein alkali is sodium hydroxide, the highly basic such as potassium hydroxide, and reaction solvent can be methyl alcohol, in the alcohols such as ethanol
(6) compound of formula VII uses suitable oxidant reaction to generate fulvestrant under 0-60 ℃ environment, and wherein oxygenant is sodium periodate, metachloroperbenzoic acid, hydrogen peroxide etc.
Figure FSA00000574547200021
CN 201110273964 2011-09-13 2011-09-13 New fulvestrant preparation method Pending CN102993257A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110273964 CN102993257A (en) 2011-09-13 2011-09-13 New fulvestrant preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110273964 CN102993257A (en) 2011-09-13 2011-09-13 New fulvestrant preparation method

Publications (1)

Publication Number Publication Date
CN102993257A true CN102993257A (en) 2013-03-27

Family

ID=47922421

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110273964 Pending CN102993257A (en) 2011-09-13 2011-09-13 New fulvestrant preparation method

Country Status (1)

Country Link
CN (1) CN102993257A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103965280A (en) * 2014-05-21 2014-08-06 天津孚音生物科技发展有限公司 Preparation method of fulvestrant intermediate
CN111116428A (en) * 2018-11-01 2020-05-08 江苏豪森药业集团有限公司 Process and intermediates for the preparation of fulvestrant
CN111393495A (en) * 2019-01-02 2020-07-10 江苏豪森药业集团有限公司 Preparation method of fulvestrant related substance E
CN111662356A (en) * 2019-03-06 2020-09-15 正大天晴药业集团股份有限公司 Impurity control method of fulvestrant

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103965280A (en) * 2014-05-21 2014-08-06 天津孚音生物科技发展有限公司 Preparation method of fulvestrant intermediate
CN103965280B (en) * 2014-05-21 2016-04-20 天津孚音生物科技发展有限公司 A kind of preparation method of fulvestrant intermediate
CN111116428A (en) * 2018-11-01 2020-05-08 江苏豪森药业集团有限公司 Process and intermediates for the preparation of fulvestrant
CN111116428B (en) * 2018-11-01 2023-09-15 江苏豪森药业集团有限公司 Process and intermediates for the preparation of fulvestrant
CN111393495A (en) * 2019-01-02 2020-07-10 江苏豪森药业集团有限公司 Preparation method of fulvestrant related substance E
CN111662356A (en) * 2019-03-06 2020-09-15 正大天晴药业集团股份有限公司 Impurity control method of fulvestrant

Similar Documents

Publication Publication Date Title
CN106749466B (en) A kind of preparation method of high-purity Austria shellfish cholic acid
CN102993257A (en) New fulvestrant preparation method
CN102060902A (en) Chenodeoxycholic acid synthesis method
CN114380879A (en) Method for preparing progesterone intermediate and progesterone by using microchannel reactor
CN102964419A (en) Preparation method of compound dienogest
CN116640088A (en) Preparation method of high-purity Lei Fen narasin
CN106986909A (en) A kind of synthetic method for being used to treat liver disease drug intermediate
CN116514704B (en) Rafenacin intermediate and preparation method thereof
CN111072499B (en) Synthesis process of ambroxol hydrochloride
CN106674084A (en) Preparation method of 2-isopropoxy-5-methyl-4-(piperidine-4-yl) aniline dihydrochloride
CN111320664B (en) Preparation method of 24-cholenenoic acid ethyl ester
CN111018936B (en) Synthesis method of fulvestrant related substance E
CN112939814B (en) Preparation method of deuterated dacarbazine intermediate
CN111018928B (en) Synthetic method and application of gastrodin hemihydrate
CN110669089B (en) Synthesis method of 6-ketoestradiol
CN111320663B (en) Preparation method of 24-cholenenoic acid ethyl ester intermediate
CN111100042A (en) Preparation method of 2-methoxy-5-sulfonamide benzoic acid
CN105732613B (en) A kind of synthetic method of 9 demethyl (+) α dihydrotetrabenazineins
CN115073313B (en) Method for synthesizing terbutaline sulfate impurity C
CN109134577A (en) A kind of -5 α of 3 Alpha-hydroxy-cholanic acid synthetic method
CN111138509B (en) Preparation method of obeticholic acid
CN109160934A (en) A kind of Vecuronium Bromide position isomer impurity preparation method
CN104387435B (en) Compound and preparation method and application thereof
CN114478672B (en) Synthesis method of HE3286
CN113788872B (en) Preparation method of androstane-2-alkene-17-ketone

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130327